You have 9 free searches left this month | for more free features.

ocular

Showing 26 - 50 of 7,951

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glaucoma Trial (Oxygen)

Not yet recruiting
  • Glaucoma
  • Oxygen
  • (no location specified)
Feb 2, 2023

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic

Recruiting
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • SBI-100 Ophthalmic Emulsion, 0.5%
  • +2 more
  • Glendale, California
  • +2 more
Nov 17, 2023

Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Vitamin D
  • Placebo
  • Taichung, Taiwan
    China Medical University Hospital
May 1, 2023

Ocular Microbiome in Health and Disease

Recruiting
  • Microbial Colonization
  • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jul 25, 2022

    Dermatochalasis of Eyelid Trial in München (Compression dressing)

    Completed
    • Dermatochalasis of Eyelid
    • Compression dressing
    • München, Germany
      Augenklink LMU
    Oct 30, 2023

    Uveal Melanoma Trial in Grand Rapids (Darovasertib)

    Recruiting
    • Uveal Melanoma
    • Grand Rapids, Michigan
      The Cancer and Hematology Centers
    Jun 14, 2023

    Parkinson's Disease, Parkinson Disease Trial in Gateshead, North Shields

    Recruiting
    • Parkinson's Disease
    • Parkinson Disease
      • Gateshead, Tyne And Wear, United Kingdom
      • +1 more
      Sep 18, 2023

      Dry Eye, Dry Eye Syndromes, Cataract Trial in Brampton (dietary supplement, drug, other)

      Not yet recruiting
      • Dry Eye
      • +2 more
      • Omega-3
      • +3 more
      • Brampton, Ontario, Canada
        Uptown Eye
      Aug 6, 2023

      Open Angle Glaucoma, Ocular Hypertension Trial in Yerevan (iDose TR)

      Recruiting
      • Open Angle Glaucoma
      • Ocular Hypertension
      • iDose TR
      • Yerevan, Armenia
        Glaukos Clinical Study Site
      Sep 25, 2023

      Surgical Menopause Using Optical Coherence Tomography (OCT)

      Completed
      • Corneal Deformity
      • +2 more
      • Optic coherence tomography
      • Batman, Turkey
        Batman education adn research hospital
      Jun 17, 2023

      Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial

      Not yet recruiting
      • Primary Open Angle Glaucoma (POAG)
      • +3 more
      • Experimental: QLS-111 ophthalmic solution, (0.015%)
      • +4 more
      • (no location specified)
      Aug 30, 2023

      Vertigo Trial in Stockholm (VEMP by bone conduction)

      Recruiting
      • Vertigo
      • VEMP by bone conduction
      • Stockholm, Sweden
        Karolinska University Hospital, Hearing and Balance Unit
      Jun 1, 2023

      Pterygium Trial (RMP-A03 - Dose 1, RMP-A03 - Dose 2, RMP-A03 Placebo)

      Not yet recruiting
      • Pterygium
      • RMP-A03 - Dose 1
      • +2 more
      • (no location specified)
      Mar 20, 2023

      Ocular Discomfort in Glaucoma Patients Using Multiple Topical

      Recruiting
      • Glaucoma
      • Ocular Surface Disease
      • Xiidra (Lifitegrast ophthalmic solution) 5%
      • Fountain Valley, California
        Doheny Eye Center UCLA
      Oct 31, 2022

      Contact Between OTX-TIC Intracameral Ocular Implant and Corneal

      Not yet recruiting
      • Corneal Endothelium
      • OCT Imaging
      • (no location specified)
      Apr 17, 2023

      Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

      Recruiting
      • Glaucoma, Suspect
      • Aberration, Corneal Wavefront
      • Low dosage selective alpha-2 receptor agonists topical eyedrop
      • High dosage selective alpha-2 receptor agonists topical eyedrop
      • Banhā, QA, Egypt
        Ahmed Abdelshafy
      Jan 2, 2023

      Biomarkers in Ocular Inflammation and Uveitis

      Enrolling by invitation
      • Uveitis
      • Ocular Inflammation
        • Bethesda, Maryland
          National Eye Institute (NEI)
        Aug 24, 2022

        Ocular Hypertension, Primary Open Angle Glaucoma Trial in Lackland Air Force Base (Nanodropper, Regular dropper)

        Recruiting
        • Ocular Hypertension
        • Primary Open Angle Glaucoma
        • Nanodropper
        • Regular dropper
        • Lackland Air Force Base, Texas
          Wilford Hall Ambulatory Surgical Center
        May 3, 2023

        Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)

        Completed
        • Glaucoma, Open-Angle
        • Hypertension, Ocular
        • NCX 470
        • Latanoprost 0.005%
        • Austin, Texas
          Texan Eye
        Nov 9, 2022

        Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /

        Completed
        • Ocular Surface Disease
        • Primary Open Angle Glaucoma
        • Tafluprost, timolol maleate
        • Taoyuan city, Taiwan
          Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
        Oct 27, 2022

        Malignant Pigmented Tumors on Ocular Surface

        Recruiting
        • Orbital Neoplasms
        • +2 more
        • screening system for ocular surface malignant tumors
        • Guangzhou, Guangdong, China
          Zhognshan Ophthalmic Center, Sun Yat-sen University
        Dec 2, 2022

        National Cohort on Congenital Defects of the Eye

        Recruiting
        • Anophthalmia
        • +4 more
          • Paris, Île-de-France, France
            RaDiCo-ACOEIL
          Jul 18, 2023

          Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)

          Recruiting
          • Ocular Hypertension
          • Latanoprostene Bunod
          • Placebo
          • Rochester, Minnesota
            Bausch Site 001
          Sep 29, 2022

          Healthy Trial in Haifa (Sleep deprivation)

          Recruiting
          • Healthy
          • Sleep deprivation
          • Haifa, Israel
            University of Haifa
          Apr 30, 2023

          Ocular Fluids in COVID-19 Survivors

          Completed
          • COVID-19
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jul 6, 2022